The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Using real-world outcomes to evaluate the predictive power of tissue-assessed genomic biomarkers for taxane versus novel hormonal therapy (NHT) outcomes in metastatic castration-resistant prostate cancer (mCRPC).
 
Ryon Graf
Employment - Epic Sciences; Foundation Medicine
Travel, Accommodations, Expenses - Epic Sciences; Foundation Medicine
 
Virginia Fisher
Employment - Foundation Medicine; Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Ole Gjoerup
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Alexa Betzig Schrock
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine; Roche
 
Russell Madison
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Samantha Morley
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Travel, Accommodations, Expenses - Foundation Medicine
 
Lei Zhong
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Travel, Accommodations, Expenses - Foundation Medicine
 
Geoffrey R. Oxnard
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Honoraria - Foundation Medicine; Guardant Health
Consulting or Advisory Role - Abbvie; AstraZeneca; DropWorks; GRAIL; Illumina; Inivata; Janssen; LOXO; Merck; Sysmex; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)
 
Jeffrey Michael Venstrom
Employment - Foundation Medicine; Genentech
Leadership - Genentech
Stock and Other Ownership Interests - Genentech
Research Funding - Foundation Medicine; Genentech/Roche
Travel, Accommodations, Expenses - Genentech; Genentech
 
Amado J. Zurita
Honoraria - Janssen; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - Infinity Pharmaceuticals